INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 94 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 34.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $15,000 | -99.2% | 11,524 | -99.1% | 0.00% | -100.0% |
| Q2 2017 | $1,958,000 | -53.6% | 1,246,959 | -4.6% | 0.04% | -53.1% |
| Q1 2017 | $4,221,000 | +133.9% | 1,306,679 | -2.3% | 0.08% | +125.0% |
| Q4 2016 | $1,805,000 | -15.0% | 1,336,821 | -1.8% | 0.04% | -16.3% |
| Q3 2016 | $2,123,000 | +9.1% | 1,360,822 | -7.0% | 0.04% | +2.4% |
| Q2 2016 | $1,946,000 | -74.9% | 1,463,042 | -0.5% | 0.04% | -74.7% |
| Q1 2016 | $7,753,000 | -32.1% | 1,471,111 | +1.2% | 0.17% | -30.5% |
| Q4 2015 | $11,414,000 | +0.4% | 1,453,981 | +8.0% | 0.24% | -5.2% |
| Q3 2015 | $11,373,000 | – | 1,345,930 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |